CROs were built to manage complexity. Over time, many have become part of it.
In this episode of Data in Biotech, Ross Katz sits down with Ander Tallett, co-founder and COO of Dash Bio and CEO of DigitalRadius, to examine how the traditional CRO model is being rethought through automation, transparency, and productization.
Ander breaks down:
>> Why legacy CRO structures slow timelines and obscure decision-making
>> How automation enables dramatically faster turnaround without sacrificing quality
>> What it actually means to productize CRO services from a customer’s perspective
>> How regulatory requirements shape, not block operational innovation
>> Why investor confidence follows teams that solve real, painful biotech problems
Listen to the full episode of Data in Biotech:
Apple: https://lnkd.in/gpi_sXKr
Spotify: https://lnkd.in/gFzcF_NX
YouTube: https://lnkd.in/gMt_kQG7